Mobia Medical will present at the Piper Sandler Healthcare Conference on December 1, 2026, discussing stroke recovery innovations.
Quiver AI Summary
Mobia Medical, Inc. has announced that its management team will participate in the Piper Sandler 38th Annual Healthcare Conference on December 1, 2026, with a presentation scheduled for 5:30 a.m. PT / 8:30 a.m. ET. The event will include one-on-one investor meetings, and the presentation will be available for live streaming as well as in an archived format on Mobia Medical’s investor webpage. The company specializes in innovations for stroke recovery, specifically with its FDA-approved Vivistim® Paired VNS™ System, which aids chronic ischemic stroke survivors in improving upper limb function through a combination of vagus nerve stimulation and functional movement. Mobia Medical is committed to enhancing stroke care for patients and their support networks.
Potential Positives
- Mobia Medical will present at the prestigious Piper Sandler 38th Annual Healthcare Conference, increasing visibility among investors and industry professionals.
- The company's Vivistim® Paired VNS™ System is the first FDA-approved implantable solution for improving upper limb function in chronic ischemic stroke survivors, highlighting its innovative approach in the medical device sector.
- The presentation includes one-on-one investor meetings, providing an opportunity for direct engagement with potential investors, which could lead to increased funding and support.
Potential Negatives
- None
FAQ
What is Mobia Medical, Inc. known for?
Mobia Medical, Inc. is a medical device company specializing in stroke recovery solutions for survivors with motor impairments.
When will Mobia Medical present at the Piper Sandler Healthcare Conference?
Mobia Medical will present on Tuesday, December 1, 2026, at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.
How can I access the webcast of Mobia Medical's presentation?
The webcast of Mobia Medical's presentation can be accessed at https://event.webcasts.com/starthere.jsp?ei=1783629&tp_key=efbad274e1.
What product does Mobia Medical offer for stroke recovery?
Mobia Medical offers the Vivistim® Paired VNS™ System, an FDA-approved implantable device for improving upper limb function post-stroke.
Who should I contact for investor relations inquiries?
Please contact Louisa Smith at Gilmartin Group, LLC via email at [email protected] for investor relations inquiries.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$MOBI Insider Trading Activity
$MOBI insiders have traded $MOBI stock on the open market 7 times in the past 6 months. Of those trades, 7 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $MOBI stock by insiders over the last 6 months:
- CASEY M TANSEY has made 5 purchases buying 85,000 shares for an estimated $995,696 and 0 sales.
- NELSON BUNKER CURNES (Chief Financial Officer) purchased 5,000 shares for an estimated $63,968
- CHASE C. LEAVITT (SEE REMARKS) purchased 2,000 shares for an estimated $20,600
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$MOBI Hedge Fund Activity
We have seen 48 institutional investors add shares of $MOBI stock to their portfolio, and 16 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FARALLON CAPITAL MANAGEMENT, L.L.C. removed 690,729 shares (-61.2%) from their portfolio in Q3 2026, for an estimated $6,527,389
- DEERFIELD MANAGEMENT COMPANY, L.P. removed 670,752 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $6,338,606
- ABERDEEN GROUP PLC added 584,570 shares (+inf%) to their portfolio in Q2 2026, for an estimated $7,833,238
- POINT72 ASSET MANAGEMENT, L.P. added 529,273 shares (+inf%) to their portfolio in Q3 2026, for an estimated $5,001,629
- AVIDITY PARTNERS MANAGEMENT LP removed 473,606 shares (-59.3%) from their portfolio in Q3 2026, for an estimated $4,475,576
- BLACKROCK, INC. added 438,924 shares (+287.2%) to their portfolio in Q3 2026, for an estimated $4,147,831
- INTEGRAL HEALTH ASSET MANAGEMENT, LLC removed 250,000 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $2,362,500
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$MOBI Analyst Ratings
Wall Street analysts have issued reports on $MOBI in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 10/20/2026
- JP Morgan issued a "Overweight" rating on 08/12/2026
- Goldman Sachs issued a "Buy" rating on 06/02/2026
To track analyst ratings and price targets for $MOBI, check out Quiver Quantitative's $MOBI forecast page.
$MOBI Price Targets
Multiple analysts have issued price targets for $MOBI recently. We have seen 4 analysts offer price targets for $MOBI in the last 6 months, with a median target of $18.0.
Here are some recent targets:
- Ryan Zimmerman from BTIG set a target price of $19.0 on 10/20/2026
- Robbie Marcus from JP Morgan set a target price of $17.0 on 08/12/2026
- David Roman from Goldman Sachs set a target price of $31.0 on 06/02/2026
- Travis Steed from B of A Securities set a target price of $16.0 on 06/02/2026
Full Release
AUSTIN, Texas, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that members of management will present and host one-on-one investor meetings at the upcoming Piper Sandler 38 th Annual Healthcare Conference in New York. The presentation will take place on Tuesday, December 1, 2026, at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.
Event: Piper Sandler 38
th
Annual Healthcare Conference
Date: Tuesday, December 1, 2026
Time: 5:30 a.m. PT / 8:30 a.m. ET
Webcast:
https://event.webcasts.com/starthere.jsp?ei=1783629&tp_key=efbad274e1
A live and archived version of the presentation will be available via the News & Events page of the investor section of Mobia Medical’s website.
About Mobia Medical, Inc.
Mobia Medical, Inc. is a medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company’s Vivistim® Paired VNS™ System is the first and only clinically validated, FDA-approved implantable solution designed to improve upper limb function in chronic ischemic stroke survivors with moderate to severe upper extremity impairments. Therapy with the Vivistim® Paired VNS™ System combines targeted vagus nerve stimulation with functional movement to promote neuroplasticity and drive meaningful improvements in motor function. Mobia Medical is mobilizing patients, providers, and care partners to establish a better way forward in stroke care.
Investor Relations Contact
Louisa Smith
Gilmartin Group, LLC
[email protected]
Media Inquiries Contact
Terri Clevenger
[email protected]